Technical Articles: Reagent Chemistry, Synthesis & Bioscience Guides

FDA-approved Drug Library: Key Facts & FAQs

FDA-approved Drug Library is a curated collection of clinically validated, regulatory-approved small molecules designed to accelerate drug repurposing, target identification, and phenotypic screening research.

Selleck Reference Number
L1300
Primary Application
Drug repurposing, phenotypic screening, target identification
Compound Status
FDA-approved, clinically validated small molecules
Supplier
Aladdin Scientific

What Is the FDA-approved Drug Library?

The FDA-approved Drug Library (Lib412023), referenced under Selleck number L1300, is a professionally curated collection of small-molecule compounds that have received approval from the U.S. Food and Drug Administration (FDA). Each compound in the library has undergone rigorous clinical evaluation, confirming an established safety and pharmacokinetic profile in humans. This makes the library an exceptionally valuable resource for researchers who wish to bypass the early-stage safety assessment steps typically required for novel chemical entities.

Because all compounds are already approved for human use, the FDA-approved Drug Library is particularly well-suited for drug repurposing studies—the systematic investigation of known drugs for new therapeutic indications—as well as for mechanistic biology, target deconvolution, and pathway analysis. The library spans a broad range of therapeutic categories and molecular targets, providing comprehensive coverage for diverse screening campaigns.

Key Applications in Drug Discovery Research

The FDA-approved Drug Library supports a wide spectrum of research applications. The following represent the most common uses reported across the drug discovery and chemical biology communities:

Drug Repurposing: Screening FDA-approved compounds against novel disease targets or in new disease models offers an accelerated pathway to the clinic. Because safety data already exist, repositioned drug candidates can often proceed more rapidly through preclinical and early clinical phases.

High-Throughput Screening (HTS): The library is formatted for compatibility with standard HTS workflows, enabling rapid, automated evaluation of compound activity across cellular or biochemical assay platforms.

Target Identification and Validation: When a phenotypic hit is identified using the FDA-approved Drug Library, the known pharmacology of FDA-approved compounds facilitates target deconvolution and biological pathway mapping.

Mechanistic and Pathway Studies: Researchers use the library to dissect signaling pathways by selectively inhibiting or activating known molecular targets, leveraging the well-characterized mechanisms of action of approved drugs.

Compound Quality, Purity, and Storage

Compounds in the FDA-approved Drug Library are manufactured and quality-controlled to research-grade standards appropriate for in vitro and in vivo screening. Each compound is typically provided with purity data confirmed by analytical methods such as HPLC and mass spectrometry; however, researchers should consult the specific certificate of analysis (CoA) supplied with each lot for exact purity values and analytical data.

Proper storage is critical to maintaining compound integrity. As a general guideline for small-molecule libraries, compounds are best stored in a dry, dark environment at the temperature specified on the product datasheet or CoA. DMSO stock solutions should be aliquoted to minimize freeze-thaw cycles, which can degrade compound potency over time. Researchers are advised to refer to the individual compound datasheets for specific storage recommendations.

Note: Specific purity thresholds and storage temperatures for Lib412023 should be confirmed from the official product datasheet or by contacting Aladdin Scientific technical support, as specifications may vary by lot.

Ordering, Format, and Technical Support

The FDA-approved Drug Library (SKU: Lib412023) is available through Aladdin Scientific. When placing an order, researchers and procurement teams should confirm the desired plate format, solvent (typically DMSO), concentration, and volume per well, as library products may be offered in various configurations to match different screening platforms.

For technical inquiries—including questions about compound coverage, assay compatibility, custom library requests, or lot-specific documentation—Aladdin Scientific's technical support team is available to assist. It is recommended that lab managers request a full compound list and representative CoA prior to purchase to ensure the library meets the specific requirements of their screening program.

For pricing, volume discounts, and delivery timelines, please contact Aladdin Scientific's sales team or visit the official product page for Lib412023 on the Aladdin Scientific website.

Frequently asked questions

What types of compounds are included in the FDA-approved Drug Library?

The FDA-approved Drug Library contains small-molecule compounds that have received FDA approval for clinical use across a range of therapeutic areas, including oncology, neurology, cardiology, anti-infectives, and more. All compounds have established human safety and pharmacokinetic profiles, making them ideal for repurposing and mechanistic studies.

How is the FDA-approved Drug Library formatted for screening?

The FDA-approved Drug Library (Lib412023) is designed for compatibility with standard high-throughput screening workflows. Specific details regarding plate format, compound concentration, solvent, and volume per well should be confirmed by consulting the official product datasheet or contacting Aladdin Scientific technical support, as configurations may vary.

What is the recommended storage condition for the FDA-approved Drug Library?

As a general best practice for small-molecule compound libraries, the FDA-approved Drug Library should be stored under dry, dark conditions at the temperature specified on the product datasheet or certificate of analysis. DMSO stock solutions should be aliquoted to avoid repeated freeze-thaw cycles. Please refer to the specific product documentation for authoritative storage guidance.

Can the FDA-approved Drug Library be used for drug repurposing research?

Yes. Drug repurposing is one of the primary applications of the FDA-approved Drug Library. Because all compounds already have FDA approval and established clinical safety data, researchers can screen them against new disease targets or models with a reduced preclinical safety burden, potentially shortening the path from discovery to clinical application.

How do I order the FDA-approved Drug Library and what documentation is available?

The FDA-approved Drug Library (SKU: Lib412023) can be ordered directly through Aladdin Scientific. Lab managers and procurement teams are encouraged to request the full compound list and certificate of analysis prior to purchase. For pricing, delivery, and custom configurations, please contact Aladdin Scientific's sales or technical support team.

References

  1. U.S. Food and Drug Administration. Drugs@FDA: FDA-Approved Drugs database. FDA.gov.
  2. Pushpakom S, et al. Drug repurposing: progress, challenges and recommendations. Nature Reviews Drug Discovery. 2019;18(1):41-58.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

Categories: Technical Articles: Reagent Chemistry, Synthesis & Bioscience Guides

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

Cite this article

Aladdin Scientific. "FDA-approved Drug Library: Key Facts & FAQs" Aladdin Knowledge Base, updated 19 nov 2026. https://www.aladdinsci.com/us_es/faqs/fda-approved-drug-library-faqs-en.html

¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?

Recordármelo más tarde

¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.

¡Vaya! Las notificaciones están desactivadas.